CoGyn Pharmaceuticals updates on reverse merger transaction
Thursday, December 10, 2015
CoGyn Pharmaceuticals SA (formerly SPAC I SA) Said on Wednesday it completed another step of reverse merger transaction with US-based CoGyn Pharmaceuticals Inc.
Intends to acquire 33.4 percent stake in CoGyn Pharmaceuticals Inc from investor.
As a result, CoGyn Pharmaceuticals Inc to become company's unit and to be listed on Warsaw Stock Exchange.
Pledged to pay an advance payment of 10 million zlotys ($2.5 million) for acquisition of CoGyn Pharmaceuticals Inc shares.
Payment was conducted as deduction of investor's liabilities towards the company.
On previous steps of reverse merger, see.
reuters.com
